share_log

Verizon | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)

Verizon | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)

Verizon | 25-NSE：由交易所申報的註銷已到期、已贖回、已兌付證券的通知
美股sec公告 ·  06/18 20:38
牛牛AI助理已提取核心訊息
The New York Stock Exchange (NYSE) has officially notified the Securities and Exchange Commission (SEC) of its intention to delist the entire class of securities from Biodexa Pharmaceuticals Plc. The notification, which follows the provisions of Rule 12d2-2(a), states that the securities will be removed from listing and registration at the start of business on July 1, 2024. This action comes after the securities were redeemed or paid at maturity on June 18, 2024. Consequently, trading of Biodexa Pharmaceuticals' securities was suspended on the same day of redemption.
The New York Stock Exchange (NYSE) has officially notified the Securities and Exchange Commission (SEC) of its intention to delist the entire class of securities from Biodexa Pharmaceuticals Plc. The notification, which follows the provisions of Rule 12d2-2(a), states that the securities will be removed from listing and registration at the start of business on July 1, 2024. This action comes after the securities were redeemed or paid at maturity on June 18, 2024. Consequently, trading of Biodexa Pharmaceuticals' securities was suspended on the same day of redemption.
紐交所已正式通知證券交易委員會（SEC）其意向，從Biodexa Pharmaceuticals Plc 註銷全部證券。通知書遵循12d2-2(a)規定，說明這些證券將在2024年7月1日開始控件從掛牌和註冊中撤除。此舉是在這些證券在2024年6月18日到期兌付或贖回之後進行的。因此，Biodexa Pharmaceuticals的證券交易於兌付當天同時被暫停。
紐交所已正式通知證券交易委員會（SEC）其意向，從Biodexa Pharmaceuticals Plc 註銷全部證券。通知書遵循12d2-2(a)規定，說明這些證券將在2024年7月1日開始控件從掛牌和註冊中撤除。此舉是在這些證券在2024年6月18日到期兌付或贖回之後進行的。因此，Biodexa Pharmaceuticals的證券交易於兌付當天同時被暫停。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。